載入...
Effect of sorafenib on des-γ-carboxyprothrombin secretion by a human hepatocellular carcinoma cell line
Patients with hepatocellular carcinoma (HCC) who respond to sorafenib have been reported to exhibit an increase in the level of des-γ-carboxyprothrombin (DCP) in the blood, subsequent to the initiation of sorafenib treatment. In the present study, the levels of secretion of DCP and DCP with more γ-c...
Na minha lista:
| 發表在: | Oncol Lett |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5530138/ https://ncbi.nlm.nih.gov/pubmed/28781657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6451 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|